Skip to main content
. 2020 Dec 31;22(1):389. doi: 10.3390/ijms22010389
AE autoimmune encephalitis
AK5 adenylate kinase 5
AMPAR α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
BBB blood-brain barrier
BG basal ganglia
CASPR2 contactin-associated protein-like 2
CJD Creutzfeldt-Jakob disease
CNS central nervous system
CRMP5 collapsin response-mediator protein-5
CSF cerebrospinal fluid
DPPX/DPP6 dipeptidyl peptidase-like protein 6
EEG electroencephalography
FDG-PET fluorodeoxyglucose-positron emission tomography
FLAIR fluid-attenuated inversion recovery
GABA-BR γ-aminobutyric acid B receptor
GAD glutamic acid decarboxylase
GlyR glycine receptor
HIV human immunodeficiency virus
HSV herpes simplex virus
HHV6 human herpesvirus 6
ICI immune checkpoint inhibitor
IL interleukin
INF-γ interferon-γ
LE limbic encephalitis
LGI1 leucine-rich, glioma inactivated 1
mGluR5 metabotropic glutamate receptor subtype 5
MRI magnetic resonance imaging
NK natural killer
NMDAR N-methyl-D-aspartate receptor
OCB oligoclonal band
PNS paraneoplastic syndrome
SLE systemic lupus erythematosus
SOX1 sex-determining region Y (SRY)-box 1
SPS stiff-person syndrome
VZV varicella zoster virus